From Ethics to Evidence: Applying Real-World Data in Oncology Trials

Real-world data (RWD) is a powerful asset for pharmaceutical sponsors looking to enhance oncology trial design, support regulatory submissions, and demonstrate real-world value. From generating external control arms to identifying patient cohorts and uncovering long-term safety signals, RWD offers strategic advantages across the development lifecycle. But as the stakes grow, so does the ethical responsibility to use RWD with transparency, fairness, and patient-centered rigor.

This webinar will explore how to ethically and effectively incorporate RWD into oncology clinical research. Industry leaders and experts will share insights on navigating consent, bias, and data provenance—while aligning with regulatory expectations and building confidence in research practices.